These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29436609)

  • 1. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
    Iwasawa T; Zhang P; Ohkawa Y; Momota H; Wakabayashi T; Ohmi Y; Bhuiyan RH; Furukawa K; Furukawa K
    Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3.
    Shibuya H; Hamamura K; Hotta H; Matsumoto Y; Nishida Y; Hattori H; Furukawa K; Ueda M; Furukawa K
    Cancer Sci; 2012 Sep; 103(9):1656-64. PubMed ID: 22632091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model.
    Ohkawa Y; Zhang P; Momota H; Kato A; Hashimoto N; Ohmi Y; Bhuiyan RH; Farhana Y; Natsume A; Wakabayashi T; Furukawa K; Furukawa K
    Cancer Sci; 2021 Sep; 112(9):3756-3768. PubMed ID: 34145699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of gangliosides in malignant properties of melanomas.
    Ohmi Y; Kambe M; Ohkawa Y; Hamamura K; Tajima O; Takeuchi R; Furukawa K; Furukawa K
    PLoS One; 2018; 13(11):e0206881. PubMed ID: 30462668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
    Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
    Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.
    Ohkawa Y; Momota H; Kato A; Hashimoto N; Tsuda Y; Kotani N; Honke K; Suzumura A; Furukawa K; Ohmi Y; Natsume A; Wakabayashi T; Furukawa K
    J Biol Chem; 2015 Jun; 290(26):16043-58. PubMed ID: 25940087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. St8sia1-deficiency in mice alters tumor environments of gliomas, leading to reduced disease severity.
    Zhang P; Ohkawa Y; Yamamoto S; Momota H; Kato A; Kaneko K; Natsume A; Farhana Y; Ohmi Y; Okajima T; Bhuiyan RH; Wakabayashi T; Furukawa K; Furukawa K
    Nagoya J Med Sci; 2021 Aug; 83(3):535-549. PubMed ID: 34552288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside GD3 synthase (GD3S), a novel cancer drug target.
    Liu J; Zheng X; Pang X; Li L; Wang J; Yang C; Du G
    Acta Pharm Sin B; 2018 Sep; 8(5):713-720. PubMed ID: 30245960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of expression of NCAM and GD3 ganglioside to motile behaviour in neoplastic glia.
    Gratsa A; Rooprai HK; Rogers JP; Martin KK; Pilkington GJ
    Anticancer Res; 1997; 17(6B):4111-7. PubMed ID: 9428343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells.
    Hamamura K; Tsuji M; Ohkawa Y; Nakashima H; Miyazaki S; Urano T; Yamamoto N; Ueda M; Furukawa K; Furukawa K
    Biochim Biophys Acta; 2008 Mar; 1780(3):513-9. PubMed ID: 18078823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
    Liang YJ; Wang CY; Wang IA; Chen YW; Li LT; Lin CY; Ho MY; Chou TL; Wang YH; Chiou SP; Lin YJ; Yu J
    Oncotarget; 2017 Jul; 8(29):47454-47473. PubMed ID: 28537895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.
    Hashimoto N; Ito S; Tsuchida A; Bhuiyan RH; Okajima T; Yamamoto A; Furukawa K; Ohmi Y; Furukawa K
    J Biol Chem; 2019 Jul; 294(28):10833-10845. PubMed ID: 31138648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disialyl gangliosides enhance tumor phenotypes with differential modalities.
    Furukawa K; Hamamura K; Ohkawa Y; Ohmi Y; Furukawa K
    Glycoconj J; 2012 Dec; 29(8-9):579-84. PubMed ID: 22763744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosignals modulated by tumor-associated carbohydrate antigens: novel targets for cancer therapy.
    Furukawa K; Hamamura K; Aixinjueluo W; Furukawa K
    Ann N Y Acad Sci; 2006 Nov; 1086():185-98. PubMed ID: 17185516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential roles of integrin-mediated signaling for the enhancement of malignant properties of melanomas based on the expression of GD3.
    Ohkawa Y; Miyazaki S; Miyata M; Hamamura K; Furukawa K; Furukawa K
    Biochem Biophys Res Commun; 2008 Aug; 373(1):14-9. PubMed ID: 18538130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.
    Longee DC; Wikstrand CJ; Månsson JE; He X; Fuller GN; Bigner SH; Fredman P; Svennerholm L; Bigner DD
    Acta Neuropathol; 1991; 82(1):45-54. PubMed ID: 1659106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers.
    Ko K; Furukawa K; Takahashi T; Urano T; Sanai Y; Nagino M; Nimura Y; Furukawa K
    Oncogene; 2006 Nov; 25(52):6924-35. PubMed ID: 16862187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.
    Cao S; Hu X; Ren S; Wang Y; Shao Y; Wu K; Yang Z; Yang W; He G; Li X
    Front Cell Dev Biol; 2023; 11():1076862. PubMed ID: 36824365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.
    Hamamura K; Furukawa K; Hayashi T; Hattori T; Nakano J; Nakashima H; Okuda T; Mizutani H; Hattori H; Ueda M; Urano T; Lloyd KO; Furukawa K
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11041-6. PubMed ID: 16040804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells.
    Ruan S; Raj BK; Lloyd KO
    J Neurochem; 1999 Feb; 72(2):514-21. PubMed ID: 9930722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.